Cornea · 2008
Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts.
Клинический случайСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Iseli Hans Peter, Thiel Michael A, Hafezi Farhad, Kampmeier Juergen, Seiler Theo
Аннотация
PURPOSE: To evaluate the efficacy of ultraviolet-corneal cross-linking (CXL) for treating infectious melting keratitis.
METHODS: Five patients with infectious keratitis associated with corneal melting were treated with CXL at the outpatient departments of the Institut für Refraktive und Ophthalmo-Chirurgie and the eye hospital at the University of Zurich. CXL was performed when the infection did not respond to systemic and topical antibiotic therapy. Follow-up after cross-linking ranged from 1 to 9 months.
RESULTS: In all cases, the progression of corneal melting was halted after CXL treatment. Emergency keratoplasty was not necessary in any of the 5 cases presented.
CONCLUSIONS: CXL is a promising option for treating patients with therapy-refractory infectious keratitis to avoid emergency keratoplasty.
METHODS: Five patients with infectious keratitis associated with corneal melting were treated with CXL at the outpatient departments of the Institut für Refraktive und Ophthalmo-Chirurgie and the eye hospital at the University of Zurich. CXL was performed when the infection did not respond to systemic and topical antibiotic therapy. Follow-up after cross-linking ranged from 1 to 9 months.
RESULTS: In all cases, the progression of corneal melting was halted after CXL treatment. Emergency keratoplasty was not necessary in any of the 5 cases presented.
CONCLUSIONS: CXL is a promising option for treating patients with therapy-refractory infectious keratitis to avoid emergency keratoplasty.